Log In
Print
BCIQ
Print
Print this Print this
 

ProSavin

  Manage Alerts
Collapse Summary General Information
Company Oxford BioMedica plc
DescriptionLentiVector carrying 3 genes encoding enzymes for dopamine synthesis
Molecular Target Not applicable
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Lentivirus
Latest Stage of DevelopmentPhase I/II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD); Treat symptoms experienced during off-periods in Parkinson's disease (PD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today